Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Cervical cancer.

Cohen PA, Jhingran A, Oaknin A, Denny L.

Lancet. 2019 Jan 12;393(10167):169-182. doi: 10.1016/S0140-6736(18)32470-X. Review.

PMID:
30638582
2.

Fully Automatic Treatment Planning for External-Beam Radiation Therapy of Locally Advanced Cervical Cancer: A Tool for Low-Resource Clinics.

Kisling K, Zhang L, Simonds H, Fakie N, Yang J, McCarroll R, Balter P, Burger H, Bogler O, Howell R, Schmeler K, Mejia M, Beadle BM, Jhingran A, Court L.

J Glob Oncol. 2019 Jan;(2019):1-9. doi: 10.1200/JGO.18.00107.

PMID:
30629457
3.

Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study.

Sapienza LG, Ning MS, Jhingran A, Lin LL, Leão CR, da Silva BB, Pellizzon ACA, Gomes MJL, Baiocchi G.

Clin Transl Radiat Oncol. 2018 Nov 22;14:40-46. doi: 10.1016/j.ctro.2018.11.007. eCollection 2019 Jan.

4.

Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases.

Salcedo MP, Sood AK, Dos Reis R, Ramalingam P, Chen C, Frumovitz M, Jhingran A, Pitcher B, Ramirez PT, Schmeler KM.

Gynecol Oncol. 2019 Jan;152(1):101-105. doi: 10.1016/j.ygyno.2018.10.035. Epub 2018 Nov 3.

PMID:
30396690
5.

Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis.

Sapienza LG, Jhingran A, Kollmeier MA, Lin LL, Calsavara VF, Gomes MJL, Baiocchi G.

Gynecol Oncol. 2018 Dec;151(3):573-578. doi: 10.1016/j.ygyno.2018.10.011. Epub 2018 Oct 15.

PMID:
30333082
6.

Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer.

Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):593-600. doi: 10.1016/j.ijrobp.2018.06.404. Epub 2018 Jul 12.

PMID:
30017792
7.

Advancing clinical research globally: Cervical cancer research network from Mexico.

Ager BJ, Gallardo-Rincón D, de León DC, Chávez-Blanco A, Chuang L, Dueñas-González A, Gómez-García E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Pérez-Plasencia C, Plante M, Poveda A, Gaffney DK.

Gynecol Oncol Rep. 2018 Jun 12;25:90-93. doi: 10.1016/j.gore.2018.06.007. eCollection 2018 Aug. Review.

8.

Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma.

Harkenrider MM, Martin B, Nieto K, Small C, Aref I, Bergman D, Chundury A, Elshaikh MA, Gaffney D, Jhingran A, Lee L, Paydar I, Ra K, Schwarz J, Thorpe C, Viswanathan AN, Small W Jr.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1069-1077. doi: 10.1016/j.ijrobp.2018.04.049. Epub 2018 Apr 24.

PMID:
29885996
9.

ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer.

Expert Panel on Women’s Imaging:, Kang SK, Reinhold C, Atri M, Benson CB, Bhosale PR, Jhingran A, Lakhman Y, Maturen KE, Nicola R, Pandharipande PV, Salazar GM, Shipp TD, Simpson L, Small W Jr, Sussman BL, Uyeda JW, Wall DJ, Whitcomb BP, Zelop CM, Glanc P.

J Am Coll Radiol. 2018 May;15(5S):S198-S207. doi: 10.1016/j.jacr.2018.03.015.

PMID:
29724422
10.

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System.

Court LE, Kisling K, McCarroll R, Zhang L, Yang J, Simonds H, du Toit M, Trauernicht C, Burger H, Parkes J, Mejia M, Bojador M, Balter P, Branco D, Steinmann A, Baltz G, Gay S, Anderson B, Cardenas C, Jhingran A, Shaitelman S, Bogler O, Schmeller K, Followill D, Howell R, Nelson C, Peterson C, Beadle B.

J Vis Exp. 2018 Apr 11;(134). doi: 10.3791/57411.

11.

Comparative systems analysis of the secretome of the opportunistic pathogen Aspergillus fumigatus and other Aspergillus species.

Vivek-Ananth RP, Mohanraj K, Vandanashree M, Jhingran A, Craig JP, Samal A.

Sci Rep. 2018 Apr 26;8(1):6617. doi: 10.1038/s41598-018-25016-4.

12.

Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP).

Ko EM, Havrilesky LJ, Alvarez RD, Zivanovic O, Boyd LR, Jewell EL, Timmins PF 3rd, Gibb RS, Jhingran A, Cohn DE, Dowdy SC, Powell MA, Chalas E, Huang Y, Rathbun J, Wright JD.

Gynecol Oncol. 2018 May;149(2):232-240. doi: 10.1016/j.ygyno.2018.02.010. Epub 2018 Mar 13.

PMID:
29544708
13.

Model for Estimating Power and Downtime Effects on Teletherapy Units in Low-Resource Settings.

McCarroll R, Youssef B, Beadle B, Bojador M, Cardan R, Famiglietti R, Followill D, Ibbott G, Jhingran A, Trauernicht C, Balter P, Court L.

J Glob Oncol. 2017 Jan 11;3(5):563-571. doi: 10.1200/JGO.2016.005306. eCollection 2017 Oct.

14.

Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.

Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH.

Gynecol Oncol. 2018 Jan;148(1):132-138. doi: 10.1016/j.ygyno.2017.10.017. Epub 2017 Oct 28.

PMID:
29089122
15.

Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma.

Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH.

Int J Gynecol Cancer. 2018 Jan;28(1):114-121. doi: 10.1097/IGC.0000000000001135.

PMID:
28930812
16.

American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature.

Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L.

Brachytherapy. 2017 Nov - Dec;16(6):1129-1143. doi: 10.1016/j.brachy.2017.07.012. Epub 2017 Sep 6.

PMID:
28888417
17.

Flow Cytometry of Lung and Bronchoalveolar Lavage Fluid Cells from Mice Challenged with Fluorescent Aspergillus Reporter (FLARE) Conidia.

Jhingran A, Kasahara S, Hohl TM.

Bio Protoc. 2016 Sep 20;6(18). pii: e1927. doi: 10.21769/BioProtoc.1927.

18.

Cervical cancer: A global health crisis.

Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN, Gaffney DK.

Cancer. 2017 Jul 1;123(13):2404-2412. doi: 10.1002/cncr.30667. Epub 2017 May 2. Review.

19.

Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.

Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):546-553. doi: 10.1016/j.ijrobp.2016.11.015. Epub 2016 Nov 17.

20.

Clinical trials in low and middle-income countries - Successes and challenges.

Grover S, Xu M, Jhingran A, Mahantshetty U, Chuang L, Small W Jr, Gaffney D.

Gynecol Oncol Rep. 2016 Nov 25;19:5-9. doi: 10.1016/j.gore.2016.11.007. eCollection 2017 Feb. Review.

21.

Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.

Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):793-800. doi: 10.1016/j.ijrobp.2016.07.035. Epub 2016 Jul 30.

22.

Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale.

Gaffney D, Small B, Kitchener H, Young Ryu S, Viswanathan A, Trimble T, Covens A, Wilailak S, Lertkhachonsuk AA, Sitathanee C, Mahantshetty U, Fisher B, Springer S, Pollatz T, Spiller A, Bacon M, Jhingran A.

Int J Gynecol Cancer. 2016 Nov;26(9):1690-1693.

PMID:
27779548
23.

Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy.

Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ.

Pract Radiat Oncol. 2017 May - Jun;7(3):e165-e173. doi: 10.1016/j.prro.2016.09.003. Epub 2016 Sep 7.

PMID:
27743802
24.

Patterns of recurrence and survival in neuroendocrine cervical cancer.

Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M.

Gynecol Oncol. 2016 Dec;143(3):552-557. doi: 10.1016/j.ygyno.2016.09.011. Epub 2016 Sep 16.

25.

ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer.

Wahl AO, Gaffney DK, Jhingran A, Yashar CM, Biagioli M, Elshaikh MA, Jolly S, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Williams NL, Small W Jr.

Oncology (Williston Park). 2016 Sep 15;30(9):816-22. Review.

26.

ACR Appropriateness Criteria® Management of Recurrent Endometrial Cancer.

Elshaikh MA, Vance S, Gaffney DK, Biagioli M, Jhingran A, Jolly S, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W Jr; Expert Panel on Radiation Oncology–Gynecology:.

Am J Clin Oncol. 2016 Oct;39(5):507-15. doi: 10.1097/COC.0000000000000318.

PMID:
27400117
27.

Big Data to the Rescue: Is there a benefit to combined-modality adjuvant therapy in endometrial cancer?

Jhingran A, Klopp A.

Gynecol Oncol. 2016 Jun;141(3):403-404. doi: 10.1016/j.ygyno.2016.05.009. No abstract available.

PMID:
27210265
28.

Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma.

Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W.

Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1191-200. doi: 10.1016/j.ijrobp.2016.02.043. Epub 2016 Feb 21.

29.

Assessing the Quality of a Radiation Oncology Case-Based, Peer-Review Program in an Integrated Academic and Community Cancer Center Network.

Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ Jr, Martinez W, Hahn SM, Famiglietti R, Kuban DA.

J Oncol Pract. 2016 Apr;12(4):e476-86. doi: 10.1200/JOP.2015.005983. Epub 2016 Mar 1.

PMID:
26931402
30.

Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge.

Kasahara S, Jhingran A, Dhingra S, Salem A, Cramer RA, Hohl TM.

J Infect Dis. 2016 Apr 15;213(8):1289-98. doi: 10.1093/infdis/jiw054. Epub 2016 Feb 9.

31.

Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist.

Lindau ST, Abramsohn EM, Baron SR, Florendo J, Haefner HK, Jhingran A, Kennedy V, Krane MK, Kushner DM, McComb J, Merritt DF, Park JE, Siston A, Straub M, Streicher L.

CA Cancer J Clin. 2016 May;66(3):241-63. doi: 10.3322/caac.21337. Epub 2016 Jan 19. Review.

32.

An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary.

Jones E, Beriwal S, Beyer D, Chino J, Jhingran A, Lee L, Michalski J, Mundt AJ, Patton C, Petersen I, Portelance L, Schwarz JK, McCloskey S.

Adv Radiat Oncol. 2015 Dec 17;1(1):26-34. doi: 10.1016/j.adro.2015.10.001. eCollection 2016 Jan-Mar.

33.

Zinc and Manganese Chelation by Neutrophil S100A8/A9 (Calprotectin) Limits Extracellular Aspergillus fumigatus Hyphal Growth and Corneal Infection.

Clark HL, Jhingran A, Sun Y, Vareechon C, de Jesus Carrion S, Skaar EP, Chazin WJ, Calera JA, Hohl TM, Pearlman E.

J Immunol. 2016 Jan 1;196(1):336-44. doi: 10.4049/jimmunol.1502037. Epub 2015 Nov 18.

34.

Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.

Sagae S, Monk BJ, Pujade-Lauraine E, Gaffney DK, Narayan K, Ryu SY, McCormack M, Plante M, Casado A, Reuss A, Chávez-Blanco A, Kitchener H, Nam BH, Jhingran A, Temkin S, Mileshkin L, Berns E, Scholl S, Doll C, Abu-Rustum NR, Lecuru F, Small W Jr; Gynecologic Cancer InterGroup Cervix Cancer brainstorming day.

Int J Gynecol Cancer. 2016 Jan;26(1):199-207. doi: 10.1097/IGC.0000000000000587.

35.

ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer.

Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W Jr.

Oncology (Williston Park). 2015 Nov;29(11):867-72, 874-5.

36.

Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

Lim K, Erickson B, Jürgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e557-65. doi: 10.1016/j.prro.2015.06.011. Epub 2015 Jul 2.

37.

Management of nodal recurrences of endometrial cancer with IMRT.

Ho JC, Allen PK, Jhingran A, Westin SN, Lu KH, Eifel PJ, Klopp AH.

Gynecol Oncol. 2015 Oct;139(1):40-6. doi: 10.1016/j.ygyno.2015.07.096. Epub 2015 Jul 17.

38.

Deploying FLAREs to Visualize Functional Outcomes of Host-Pathogen Encounters.

Heung LJ, Jhingran A, Hohl TM.

PLoS Pathog. 2015 Jul 9;11(7):e1004912. doi: 10.1371/journal.ppat.1004912. eCollection 2015 Jul. Review. No abstract available.

39.

High-Grade Cervical Dysplasia following Radiation Therapy for Invasive Cervical Cancer: A Report of Four Cases.

Salcedo MP, Milbourne AM, Jhingran A, Eifel PJ, Ramirez PT, Schmeler KM.

Case Rep Oncol. 2015 May 6;8(2):217-21. doi: 10.1159/000382117. eCollection 2015 May-Aug.

40.

Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014.

Jeffery DD, Barbera L, Andersen BL, Siston AK, Jhingran A, Baron SR, Reese JB, Coady DJ, Carter J, Flynn KE.

J Psychosoc Oncol. 2015;33(4):433-66. doi: 10.1080/07347332.2015.1046012. Review.

41.

NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer.

Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK.

Cancer. 2015 Jul 1;121(13):2156-63. doi: 10.1002/cncr.29337. Epub 2015 Apr 6.

42.

Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer: outcomes of patients treated with radiotherapy.

Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH.

Int J Gynecol Cancer. 2015 Jun;25(5):869-74. doi: 10.1097/IGC.0000000000000424.

PMID:
25790043
43.

Ovarian torsion after laparoscopic ovarian transposition in patients with gynecologic cancer: a report of two cases.

Gómez-Hidalgo NR, Darin MC, Dalton H, Jhingran A, Fleming N, Brown J, Ramirez PT.

J Minim Invasive Gynecol. 2015 May-Jun;22(4):687-90. doi: 10.1016/j.jmig.2015.02.009. Epub 2015 Mar 12.

PMID:
25772021
44.

Antecedents and mediators of physical activity in endometrial cancer survivors: Increasing physical activity through steps to health.

Cox M, Carmack C, Hughes D, Baum G, Brown J, Jhingran A, Lu K, Basen-Engquist K.

Health Psychol. 2015 Oct;34(10):1022-32. doi: 10.1037/hea0000188. Epub 2015 Feb 2.

45.

Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection.

Jhingran A, Kasahara S, Shepardson KM, Junecko BA, Heung LJ, Kumasaka DK, Knoblaugh SE, Lin X, Kazmierczak BI, Reinhart TA, Cramer RA, Hohl TM.

PLoS Pathog. 2015 Jan 26;11(1):e1004589. doi: 10.1371/journal.ppat.1004589. eCollection 2015 Jan.

46.

Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer.

Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH.

Brachytherapy. 2015 May-Jun;14(3):385-9. doi: 10.1016/j.brachy.2014.12.005. Epub 2015 Jan 22.

PMID:
25620163
47.

Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system?

Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ.

Gynecol Oncol. 2015 Feb;136(2):269-73. doi: 10.1016/j.ygyno.2014.12.013. Epub 2014 Dec 16.

48.

Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer.

Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ.

Obstet Gynecol. 2014 Dec;124(6):1098-104. doi: 10.1097/AOG.0000000000000558.

49.

Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.

Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):320-8. doi: 10.1016/j.ijrobp.2014.06.005.

50.

Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection.

Shepardson KM, Jhingran A, Caffrey A, Obar JJ, Suratt BT, Berwin BL, Hohl TM, Cramer RA.

PLoS Pathog. 2014 Sep 25;10(9):e1004378. doi: 10.1371/journal.ppat.1004378. eCollection 2014 Sep.

Supplemental Content

Loading ...
Support Center